Document is current
Any future updates will be listed below
-
Authors
Takis, Panteleimon G. https://orcid.org/0000-0002-7224-0412
Schäfer, Hartmut
Spraul, Manfred
Luchinat, Claudio https://orcid.org/0000-0003-2271-8921
- License Information
-
More Information
Article History
Received: 3 May 2017
Accepted: 29 September 2017
First Online: 21 November 2017
Competing interests
: Bruker Biospin is performing method development in bodyfluid analysis to generate products to enhance the performance of its users in metabolic analysis, which is a necessity for successful application of NMR in, e.g., translational/clinical, epidemiological, and pharma research. Giotto Biotech will be offering customer services based on the Bruker IVDr platform and the present predictor.
